EverSource Wealth Advisors, LLC
Position in ORGO — Organogenesis Holdings Inc.
CIK 1710537
BIRMINGHAM, AL
Position in ORGO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,660
+$2,990 QoQ
Shares Held
1,507
+432.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#113
of 135 holders
Holding Since
Dec 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EverSource Wealth Advisors, LLC holds $2,810,448 across 53 Drug Manufacturers - Specialty & Generic names. ORGO ranks #29 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,136 | $528,538 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
789 | $427,499 | |
| 3 | HLN |
Haleon plc
|
32,803 | $306,048 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
16,089 | $257,903 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
6,009 | $188,681 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
5,126 | $185,557 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
5,767 | $141,922 | |
| 8 | ZTS |
Zoetis Inc.
|
1,468 | $105,486 |
All Filings in ORGO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,660 | 1,507 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $670 | 283 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $233 | 45 | Shares | Sole | 2026-02-06 | |
| 2025-03-31 | $1,088 | 252 | Shares | Sole | 2025-05-13 | |
| 2023-03-31 | $1,904 | 894 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,733 | 2,503 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||